Enveda secures $311M to bring more nature-derived AI drugs into clinical trials | TechCrunch



Posted on Thu Sep 24 2026 | 1:01 am


The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.




Search
Side Widget
You can put anything you want inside of these side widgets. They are easy to use, and feature the new Bootstrap 4 card containers!